BURLINGTON, Mass., Oct. 29, 2019 /PRNewswire/ -- Decision Resources Group, www.decisionresourcesgroup.com, a premier provider of high-value healthcare data, analy

MARLBOROUGH, Mass., Oct. 29, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, announced today that several posters featuring INTASYL™ will  be presented at the Society for Imm

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2019 /PRNewswire/ -- Genome Medical, a leader in telegenomics clinical care, today unveiled Genome Care DeliveryTM, a technology platform

WELLINGTON, New Zealand, Oct. 29, 2019 /PRNewswire/ -- Volpara Solutions, an industry leader in cancer screening workflow, today announced the expansion of its global Medical Adviso

CAMBRIDGE, Mass., Oct. 29, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ:BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it will host a Research and Development (R&D) Day for analysts and investors on Tuesday, November 5, 2

LEXINGTON, Mass., Oct. 29, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its third quarter financial results on Tuesday, November 5, 2019, after the close of US markets. Management w

VANCOUVER, British Columbia, Oct. 29, 2019 /PRNewswire/ -- Pasha Brands Ltd. ("Pasha") (CSE: CRFT) (OTC: CRFTF) (FSE: ZZD). Between 2014 and 2018 global sales of legal cannabis more than tripled from $3.4 billion to $10.9 billion, according to the State of the Legal Cannabis Markets report from Arcvi

MISGAV, Israel, Oct. 29, 2019 /PRNewswire/ -- Gordian Surgical Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T; OTCQX: TRNLY), is pleased to announce that it has raised

HOUSTON, Oct. 29, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), discussed multiple additional indications that may be possible target

ALPHARETTA, Ga., Oct. 29, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2019 on Tuesday, Nov. 5 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens th